Parkinson's disease (PD) and atypical Parkinsonian syndromes are progressive heterogeneous neurodegenerative diseases that share clinical characteristic of parkinsonism as a common feature, but are ...

Elizabeth's Medical Center in Boston. Her expertise is treating patients with Parkinson’s Disease, Atypical Parkinson’s, Essential tremor and other movement disorders. She is also a Board ...

Although curing Parkinson's disease is not yet possible, treatment for movement disorders is a field in transformation. Every year, more insights on underlying causes and techniques for managing ...

4 Sarah Koe PSP Research Centre, UCL Institute of Neurology, London, UK 5 Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK Objective To evaluate in ...

said it “stands ready to work together to bring the promise of the National Plan to fruition on behalf of everyone touched by Parkinson’s and atypical parkinsonisms.” “When we started the ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Occasional atypical lymphomonocytoid cells were seen ... to the full regimen exhibited a relatively mild unilateral type of Parkinson's disease. The mechanisms by which the effects described ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists have been able to identify patterns of neurodegeneration and create ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month that mold exposure in a rented apartment caused Parkinson's disease in a ...

Parkinson's disease is a progressive disorder that develops when the brain cells that produce dopamine (a chemical involved in movement) stop working or die. When this happens, symptoms like slowed ...